FI932874A0 - 6,7-modifierade 11b-aryl-4-estrener - Google Patents

6,7-modifierade 11b-aryl-4-estrener

Info

Publication number
FI932874A0
FI932874A0 FI932874A FI932874A FI932874A0 FI 932874 A0 FI932874 A0 FI 932874A0 FI 932874 A FI932874 A FI 932874A FI 932874 A FI932874 A FI 932874A FI 932874 A0 FI932874 A0 FI 932874A0
Authority
FI
Finland
Prior art keywords
pct
hydrogen atom
sec
atom
alkyl radical
Prior art date
Application number
FI932874A
Other languages
English (en)
Other versions
FI932874A (fi
Inventor
Eckhard Ottow
Wolfgang Schwede
Arwed Cleve
Walter Elger
Krzysztof Chwalisz
Martin Schneider
Ulrike Fuhrmann
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of FI932874A0 publication Critical patent/FI932874A0/fi
Publication of FI932874A publication Critical patent/FI932874A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0092—Alkenyl derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Internal Circuitry In Semiconductor Integrated Circuit Devices (AREA)
  • Photovoltaic Devices (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Holo Graphy (AREA)
  • Semiconductor Memories (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI932874A 1990-12-22 1993-06-21 6,7-modifierade 11b-aryl-4-estrener FI932874A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4042007A DE4042007A1 (de) 1990-12-22 1990-12-22 6,7-modifizierte-11(beta)-aryl-4-estrene
PCT/EP1991/002493 WO1992011277A1 (de) 1990-12-22 1991-12-21 6,7-MODIFIZIERTE 11β-ARYL-4-ESTRENE

Publications (2)

Publication Number Publication Date
FI932874A0 true FI932874A0 (fi) 1993-06-21
FI932874A FI932874A (fi) 1993-06-21

Family

ID=6421578

Family Applications (1)

Application Number Title Priority Date Filing Date
FI932874A FI932874A (fi) 1990-12-22 1993-06-21 6,7-modifierade 11b-aryl-4-estrener

Country Status (16)

Country Link
US (1) US5843931A (fi)
EP (1) EP0565553B1 (fi)
JP (1) JP3181589B2 (fi)
CN (1) CN1065070A (fi)
AT (1) ATE182334T1 (fi)
AU (2) AU9098191A (fi)
CA (1) CA2099018A1 (fi)
DE (2) DE4042007A1 (fi)
FI (1) FI932874A (fi)
HU (1) HUT67311A (fi)
IE (1) IE914529A1 (fi)
IL (1) IL100465A (fi)
NO (1) NO932277L (fi)
PT (1) PT99911B (fi)
WO (1) WO1992011277A1 (fi)
ZA (1) ZA9110144B (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI3263112T1 (sl) 2006-10-24 2020-10-30 Allergan Pharmaceuticals International Limited Sestavki in metode za zaviranje endometrijskih proliferacij
TWI539953B (zh) 2008-04-28 2016-07-01 瑞波若斯治療學公司 用於治療乳癌之組成物和方法
HUP0900487A2 (hu) * 2009-08-05 2011-03-28 Richter Gedeon Nyrt 17-acetoxi-11ß-[4-(dimetil-amino)-fenil]-21-metoxi-19-norpregna-4,9-dién-3,20-dion új kristályos polimorf módosulata és eljárás elõállítására
CN107260745A (zh) 2010-03-22 2017-10-20 利普生物药剂公司 用于抗孕酮的非毒性递送的组合物和方法
JP6906525B2 (ja) 2015-12-23 2021-07-21 オリック ファーマシューティカルズ，インク． グルココルチコイド受容体の阻害剤
WO2017112904A1 (en) 2015-12-23 2017-06-29 Oric Pharmaceuticals, Inc. Inhibitors of glucocorticoid receptor
JP6995757B2 (ja) 2015-12-23 2022-01-17 オリック ファーマシューティカルズ，インク． グルココルチコイド受容体の阻害剤
PL3523315T3 (pl) 2016-10-07 2021-10-18 Oric Pharmaceuticals, Inc. Inhibitor receptora glukokortykoidowego
TW202010502A (zh) * 2018-04-11 2020-03-16 美商歐瑞克製藥公司 包含糖皮質激素受體拮抗劑之固體形式與調配物及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ214998A (en) * 1985-02-07 1989-06-28 Schering Ag 13-(methyl or ethyl)-11-beta-phenyl-gonane derivatives; preparatory processes and pharmaceutical compositions
DE3702383A1 (de) * 1987-01-23 1988-08-04 Schering Ag 11ss-alkinylestrene und -estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
DE3921059A1 (de) * 1989-06-23 1991-01-10 Schering Ag 11(beta)-aryl-4-estrene, verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel
DE4018167A1 (de) * 1990-06-01 1991-12-05 Schering Ag Verfahren zur herstellung von 10(beta)-h-steroiden
DE4018168A1 (de) * 1990-06-01 1991-12-05 Schering Ag Ausgangsverbindungen fuer die herstellung von 10ss-h-steroiden und ein verfahren zur herstellung dieser ausgangsverbindungen

Also Published As

Publication number Publication date
NO932277L (no) 1993-08-20
JPH06505707A (ja) 1994-06-30
ZA9110144B (en) 1992-10-28
CN1065070A (zh) 1992-10-07
HUT67311A (en) 1995-03-28
ATE182334T1 (de) 1999-08-15
US5843931A (en) 1998-12-01
IE914529A1 (en) 1992-07-01
NO932277D0 (no) 1993-06-21
FI932874A (fi) 1993-06-21
HU9301815D0 (en) 1993-09-28
PT99911A (pt) 1992-12-31
PT99911B (pt) 1999-06-30
CA2099018A1 (en) 1992-06-23
DE59109142D1 (de) 1999-08-26
AU9098191A (en) 1992-07-22
EP0565553B1 (de) 1999-07-21
JP3181589B2 (ja) 2001-07-03
DE4042007A1 (de) 1992-06-25
IL100465A (en) 1997-03-18
AU3773395A (en) 1996-01-11
EP0565553A1 (de) 1993-10-20
WO1992011277A1 (de) 1992-07-09

Similar Documents

Publication Publication Date Title
IL94077A0 (en) Lipopolyamines,their preparation and application
FI912998A0 (fi) Foerfarande foer framstaellning av aralifatiskt n-substituerade aminoalkanfosfinsyror.
AU4306796A (en) Novel 3,5-dioxo-(2h,4h)-1,2,4-triazine derivatives, their preparation and use as drugs
AU1884092A (en) Novel derivatives of perhydroisoindole and preparation thereof
NZ239165A (en) Drug conjugate (a-o-w-z) a -t, the crosslinking group containing a cycloalkyl ring, and pharmaceutical compositions
IL73893A (en) 11-aryl-13-estradiene derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
EP0482410A3 (en) Anti-microbial compounds, including substituted 2-cyclohexyl-amine derivatives and their preparation
FI932874A0 (fi) 6,7-modifierade 11b-aryl-4-estrener
NZ224367A (en) Insect and mite repelling agent containing at least one substituted #a#, #l#-aminoalcohol
IL98262A0 (en) Chromone derivatives and pharmaceutical compositions containing them
PT79839B (en) Process for the preparation of 6,6-ethylene-15,16-methylene-3-oxi-17alpha-pregn-4-ene-21,17-carbolactones and pharmaceutical compositions therewith
BG106235A (en) Streptogramin derivatives, preparation and compositions containing them
AU659118B2 (en) 14beta-H-, 14- and 15-EN-11beta -aryl-4-estrenes
HK1033455A1 (en) Novel tricyclic compounds, preparation method and pharmaceutical compositions containing same
ZA958861B (en) 6-polyfluroalkoxy- and 6-polyfluoroalkyl-2-aminobenzothiazole derivatives
IL107232A0 (en) 19, 11-bridged 4-estrene derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same
DK0539486T3 (da) Fremgangsmåde til fremstilling af streptograminderivater

Legal Events

Date Code Title Description
FD Application lapsed